| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029825797 |
| P356 | DOI | 10.1186/1477-7827-9-48 |
| P932 | PMC publication ID | 3096916 |
| P698 | PubMed publication ID | 21496272 |
| P5875 | ResearchGate publication ID | 51054253 |
| P50 | author | Julian K Christians | Q57452653 |
| P2093 | author name string | Pamela K Wagner | |
| Aki Otomo | |||
| P2860 | cites work | Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase | Q24290962 |
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3 | Q28137996 | ||
| ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3 | Q28138723 | ||
| Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialisation in pre-eclampsia | Q28205314 | ||
| Transcriptional effects of hypoxia on fusiogenic syncytin and its receptor ASCT2 in human cytotrophoblast BeWo cells and in ex vivo perfused placental cotyledons | Q28206002 | ||
| A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies | Q28239787 | ||
| In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies | Q28350804 | ||
| Altered placental expression of PAPPA2 does not affect birth weight in mice | Q34036198 | ||
| Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury | Q34315001 | ||
| Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions | Q34432383 | ||
| Searching for preeclampsia genes: the current position. | Q34967445 | ||
| Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. | Q35007511 | ||
| Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
| Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. | Q35096089 | ||
| The genetics of pre-eclampsia: a feto-placental or maternal problem? | Q35177399 | ||
| Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 | Q35835673 | ||
| Human placental explants in culture: approaches and assessments. | Q36159671 | ||
| Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. | Q37072792 | ||
| What matters in preeclampsia are the associated adverse outcomes: the view from Canada | Q37128593 | ||
| Predicting adverse outcomes in women with severe pre-eclampsia | Q37493258 | ||
| Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar | Q37567589 | ||
| Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction | Q37775591 | ||
| An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). | Q38521938 | ||
| Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation | Q39842515 | ||
| Does altered oxygenation or reactive oxygen species alter cell turnover of BeWo choriocarcinoma cells? | Q39894990 | ||
| Morphological and electrical properties of human trophoblast choriocarcinoma, BeWo cells | Q39990983 | ||
| Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast | Q40245845 | ||
| Quantifying the syncytialisation of human placental trophoblast BeWo cells grown in vitro | Q40658401 | ||
| Type I insulin-like growth factor receptors in the BeWo choriocarcinoma cell (b30 clone) during cell differentiation | Q41187495 | ||
| Transforming growth factor beta 1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion | Q41864326 | ||
| Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase | Q42544761 | ||
| Regulation of telomerase during human placental differentiation: a role for TGFbeta1. | Q43713644 | ||
| Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. | Q44044678 | ||
| Seven placental transcripts characterize HELLP-syndrome | Q44198059 | ||
| Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin | Q44369600 | ||
| Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts | Q44764098 | ||
| TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas | Q45102738 | ||
| Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua | Q46337697 | ||
| Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach | Q46340721 | ||
| Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse | Q47714215 | ||
| Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth | Q47864591 | ||
| Differential placental gene expression in severe preeclampsia. | Q51794890 | ||
| The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies. | Q53851391 | ||
| Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. | Q54515085 | ||
| Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. | Q54696377 | ||
| Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells | Q57104820 | ||
| BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-gamma, interleukin-10 and transforming growth factor-beta1 | Q58439005 | ||
| Factors Involved in Regulating Trophoblast Fusion: Potential Role in the Development of Preeclampsia | Q61865443 | ||
| E-cadherin expression during the differentiation of human trophoblasts | Q67895069 | ||
| Spontaneous and induced release of prostaglandins, interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha by placental tissue from normal and preeclamptic pregnancies | Q73327506 | ||
| Cell culture models of trophoblast II: trophoblast cell lines--a workshop report | Q73833688 | ||
| Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group | Q73937666 | ||
| First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system | Q79719770 | ||
| ADAM12s in maternal serum as a potential marker of pre-eclampsia | Q80673251 | ||
| Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension | Q81058982 | ||
| Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia | Q81920292 | ||
| In-cell Western assay: a new approach to visualize tissue factor in human monocytes | Q82050362 | ||
| Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester | Q83106769 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 48 | |
| P577 | publication date | 2011-04-15 | |
| P1433 | published in | Reproductive Biology and Endocrinology | Q15767218 |
| P1476 | title | Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo). | |
| P478 | volume | 9 |
| Q40874719 | ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts |
| Q39154049 | AP-2α suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin |
| Q34231494 | Comprehensive analysis of preeclampsia-associated DNA methylation in the placenta |
| Q38430192 | Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis |
| Q33593480 | First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia |
| Q34740473 | IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells |
| Q42773995 | Impaired function of trophoblast cells derived from translocated hESCs may explain pregnancy loss in women with balanced translocation (11;22). |
| Q55283167 | PAPP-A2 deficiency does not exacerbate the phenotype of a mouse model of intrauterine growth restriction. |
| Q36104997 | Pappa2 deletion in mice affects male but not female fertility |
| Q54257063 | Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR. |
| Q58593104 | Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics |
| Q99581537 | Serum proteins differentially expressed in early- and late-onset preeclampsia assessed using iTRAQ proteomics and bioinformatics analyses |
Search more.